In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
RNA therapeutics target translation rather than DNA, aiming to correct shared protein production errors. By enabling cells to read through premature stop codons, engineered tRNAs could restore ...
A pioneer in muscle-tissue engineering is highlighting the challenges of bringing novel therapies to the clinic.
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results